Hospira Reports Fourth-Quarter and Full-Year 20...( -- Provides Sales and Earn...),Health

-- Provides Sales and Earnings Projections for 2008 --

LAKE FOREST, Ill., Feb. 28 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today reported results for the fourth quarter and full year ended Dec. 31, 2007.

Fourth Quarter:

-- Net sales increased 33.9 percent to $946.1 million in the fourth

quarter of 2007, compared to $706.5 million in the fourth quarter last

year. Net sales excluding Mayne Pharma sales grew 8.4 percent.

-- Adjusted* fourth-quarter 2007 diluted earnings per share were $0.63

versus $0.43 in 2006. GAAP fourth-quarter 2007 diluted earnings per

share were $0.47 versus $0.30 for the same period last year.

Full Year:

-- Net sales increased 27.8 percent to $3.44 billion versus $2.69 billion

in 2006. Net sales excluding Mayne Pharma sales grew 4.1 percent.

-- Adjusted* full-year 2007 diluted earnings per share were $2.19 versus

$1.94 last year. GAAP full-year 2007 diluted earnings per share were

$0.85 versus $1.48 in 2006.

"In 2007, Hospira delivered another strong year of revenue and profit growth, and we are energized as we begin 2008," said Christopher B. Begley, chairman and chief executive officer. "We are advancing our global performance and long-term goals with an increased focus on innovating our products and business to meet healthcare needs worldwide."

Significant Events in 2007

-- Completed the Mayne Pharma acquisition and made significant progress

integrating the two organizations. Hospira attained its acquisition-

related operational and financial milestones, including red
'/>"/>